Primary |
International Normalised Ratio Increased |
66.7% |
Blood Disorder |
33.3% |
|
Infusion Related Reaction |
33.3% |
Loss Of Consciousness |
33.3% |
Vomiting |
33.3% |
|
Secondary |
Drug Use For Unknown Indication |
60.4% |
Product Used For Unknown Indication |
6.0% |
Deep Vein Thrombosis |
4.5% |
Cerebrovascular Accident Prophylaxis |
3.0% |
Epilepsy |
3.0% |
Pain |
3.0% |
Subdural Haematoma |
3.0% |
Hypertension |
2.2% |
Pregnancy |
2.2% |
Anticoagulant Therapy |
1.5% |
Anxiety |
1.5% |
Colon Cancer Metastatic |
1.5% |
Depression |
1.5% |
Hiv Infection |
1.5% |
Rheumatic Fever |
1.5% |
Accidental Exposure |
0.7% |
International Normalised Ratio Abnormal |
0.7% |
International Normalised Ratio Increased |
0.7% |
Off Label Use |
0.7% |
Parachute Mitral Valve |
0.7% |
|
Toxic Epidermal Necrolysis |
20.0% |
International Normalised Ratio Increased |
12.0% |
Urticaria Generalised |
12.0% |
Lung Abscess |
8.0% |
Hepatic Failure |
4.0% |
Hypersensitivity |
4.0% |
International Normalised Ratio Fluctuation |
4.0% |
Myalgia |
4.0% |
Peripheral Vascular Disorder |
4.0% |
Rash |
4.0% |
Renal Failure Acute |
4.0% |
Secretion Discharge |
4.0% |
Urinary Tract Infection |
4.0% |
Ventricular Fibrillation |
4.0% |
White Blood Cell Count Decreased |
4.0% |
Wrong Drug Administered |
4.0% |
|
Concomitant |
Drug Use For Unknown Indication |
36.6% |
Product Used For Unknown Indication |
17.6% |
Prophylaxis |
7.8% |
Pain |
5.0% |
Crohn's Disease |
3.2% |
Thrombocytopenia |
3.2% |
Hypertension |
3.0% |
Coagulopathy |
2.9% |
Vitamin Supplementation |
2.3% |
Nausea |
2.0% |
Atrial Fibrillation |
1.9% |
Thrombosis Prophylaxis |
1.9% |
Epilepsy |
1.8% |
Neck Pain |
1.7% |
Constipation |
1.6% |
Asthma |
1.5% |
Acute Lymphocytic Leukaemia |
1.5% |
Hepatic Neoplasm Malignant |
1.5% |
Vomiting |
1.5% |
Foetal Exposure During Pregnancy |
1.4% |
|
Vomiting |
10.1% |
Sepsis |
9.7% |
Thrombocytopenia |
9.2% |
Renal Failure |
8.3% |
Septic Shock |
6.5% |
Weight Increased |
6.0% |
Weight Decreased |
5.5% |
Renal Failure Acute |
5.1% |
International Normalised Ratio Increased |
4.6% |
White Blood Cell Count Decreased |
4.1% |
Wound Infection |
4.1% |
Multi-organ Failure |
3.2% |
Pneumonia |
3.2% |
Rectal Haemorrhage |
3.2% |
Tachycardia |
3.2% |
Hepatic Failure |
2.8% |
Neutropenia |
2.8% |
Pulmonary Embolism |
2.8% |
Urinary Retention |
2.8% |
Urinary Tract Infection |
2.8% |
|
Interacting |
Vitamin Supplementation |
100.0% |
|
Haemorrhoidal Haemorrhage |
100.0% |
|